Article R5222-16 of the French Public Health Code
At the request of the Director General of the Agence nationale de sécurité du médicament et des produits de santé, the manufacturer or its authorised representative shall provide any information relating to the characteristics, design, composition, analytical evaluation file, manufacture, storage, distribution, instructions for use, batch control procedures and results before release and during use, the making available, use and traceability of in vitro diagnostic medical devices and their sale….